share_log

Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer VARKI PAUL

SEC announcement ·  Jun 25 16:12
Summary by Moomoo AI
Paul Varki, the Chief Legal Officer of Avalo Therapeutics, Inc., was involved in a transaction with the company's stock on June 24, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Following the action, the updated number of shares held by Varki was also not provided. This information is crucial for investors to understand the insider activity within Avalo Therapeutics and may influence their investment decisions.
Paul Varki, the Chief Legal Officer of Avalo Therapeutics, Inc., was involved in a transaction with the company's stock on June 24, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Following the action, the updated number of shares held by Varki was also not provided. This information is crucial for investors to understand the insider activity within Avalo Therapeutics and may influence their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more